[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2058025A1 - Aplicacion del acido fitico y/o sus fitatos en los estados patologicos y prepatologicos derivados de la litiasis renal oxalocalcica idiopatica. - Google Patents

Aplicacion del acido fitico y/o sus fitatos en los estados patologicos y prepatologicos derivados de la litiasis renal oxalocalcica idiopatica.

Info

Publication number
ES2058025A1
ES2058025A1 ES09202492A ES9202492A ES2058025A1 ES 2058025 A1 ES2058025 A1 ES 2058025A1 ES 09202492 A ES09202492 A ES 09202492A ES 9202492 A ES9202492 A ES 9202492A ES 2058025 A1 ES2058025 A1 ES 2058025A1
Authority
ES
Spain
Prior art keywords
oxalocalcic
phytates
lithiasis
renal
pathological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09202492A
Other languages
English (en)
Other versions
ES2058025B1 (es
Inventor
Freixedas Feliciano Grases
Isern Juan Gabriel March
Bauza Antonio Costa
Almirall Rafael Maria Prieto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Authex S A Lab
Universitat de les Illes Balears
Original Assignee
Authex S A Lab
Universitat de les Illes Balears
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Authex S A Lab, Universitat de les Illes Balears filed Critical Authex S A Lab
Priority to ES9202492A priority Critical patent/ES2058025B1/es
Publication of ES2058025A1 publication Critical patent/ES2058025A1/es
Application granted granted Critical
Publication of ES2058025B1 publication Critical patent/ES2058025B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

APLICACION DEL ACIDO FITICO Y/O SUS FITATOS EN LOS ESTADOS PATOLOGICOS Y PREPATOLOGICOS DERIVADOS DE LA LITIASIS RENAL OXALOCALCICA IDIOPATICA. COMPRENDE LA NUEVA APLICACION DEL ACIDO FITICO Y/O SUS FITATOS FARMACEUTICAMENTE ACEPTABLES COMO INHIBIDORES DE LA FORMACION DE CRISTALES DE OXALATO CALCICO EN EL RIÑON. ASIMISMO, COMPRENDE LA APLICACION DE DICHOS PRODUCTOS PARA EL TRATAMIENTO DE LOS ESTADOS PATOLOGICOS O PREPATOLOGICOS DERIVADOS DE LA LITIASIS RENAL OXALOCALCICA IDIOPATICA. ADICIONALMENTE, COMPRENDE LA UTILIZACION DEL ACIDO FITICO Y/O SUS FITATOS FARMACEUTICAMENTE ACEPTABLES EN LA FABRICACION DE MEDICAMENTOS PARA EL TRATAMIENTO Y/O PREVENCION DE LA LITIASIS RENAL OXALOCALCICA.
ES9202492A 1992-12-04 1992-12-04 Aplicacion del acido fitico y/o sus fitatos en los estados patologicos y prepatologicos derivados de la litiasis renal oxalocalcica idiopatica. Expired - Fee Related ES2058025B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9202492A ES2058025B1 (es) 1992-12-04 1992-12-04 Aplicacion del acido fitico y/o sus fitatos en los estados patologicos y prepatologicos derivados de la litiasis renal oxalocalcica idiopatica.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9202492A ES2058025B1 (es) 1992-12-04 1992-12-04 Aplicacion del acido fitico y/o sus fitatos en los estados patologicos y prepatologicos derivados de la litiasis renal oxalocalcica idiopatica.

Publications (2)

Publication Number Publication Date
ES2058025A1 true ES2058025A1 (es) 1994-10-16
ES2058025B1 ES2058025B1 (es) 1995-10-01

Family

ID=8279051

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9202492A Expired - Fee Related ES2058025B1 (es) 1992-12-04 1992-12-04 Aplicacion del acido fitico y/o sus fitatos en los estados patologicos y prepatologicos derivados de la litiasis renal oxalocalcica idiopatica.

Country Status (1)

Country Link
ES (1) ES2058025B1 (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001005249A1 (es) * 1999-07-16 2001-01-25 Universitat De Les Illes Balears Aplicacion de harinas de germen de ciertos cereales en la fabricacion de productos alimenticios utiles para el tratamiento de estados carenciales en fitatos
ES2555166A1 (es) * 2014-06-25 2015-12-29 Universitat De Les Illes Balears Composiciones de ácido fitico, magnesio y polifenoles y su aplicación para la prevención de la litiasis renal oxalocálcica

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2007238A6 (es) * 1988-06-17 1989-06-01 Univ Illes Balears Procedimiento para la preparacion de fitato-zn (ii)>
EP0390574A2 (en) * 1989-03-31 1990-10-03 Sanwa Kagaku Kenkyusho Co., Ltd. Compositions of phytic acid, and pharmaceutical uses thereof
EP0420428A2 (en) * 1989-09-13 1991-04-03 Robert Sabin Mehod of treatment of rheumatoid arthritis using phytic acid

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2007238A6 (es) * 1988-06-17 1989-06-01 Univ Illes Balears Procedimiento para la preparacion de fitato-zn (ii)>
EP0390574A2 (en) * 1989-03-31 1990-10-03 Sanwa Kagaku Kenkyusho Co., Ltd. Compositions of phytic acid, and pharmaceutical uses thereof
EP0420428A2 (en) * 1989-09-13 1991-04-03 Robert Sabin Mehod of treatment of rheumatoid arthritis using phytic acid

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001005249A1 (es) * 1999-07-16 2001-01-25 Universitat De Les Illes Balears Aplicacion de harinas de germen de ciertos cereales en la fabricacion de productos alimenticios utiles para el tratamiento de estados carenciales en fitatos
ES2152899A1 (es) * 1999-07-16 2001-02-01 Univ Illes Balears Aplicacion de harinas de germen de ciertos cereales en la fabricacion de productos alimenticios utiles para el tratamiento de estados carenciales en fitatos.
ES2555166A1 (es) * 2014-06-25 2015-12-29 Universitat De Les Illes Balears Composiciones de ácido fitico, magnesio y polifenoles y su aplicación para la prevención de la litiasis renal oxalocálcica
WO2015197892A1 (es) * 2014-06-25 2015-12-30 Universitat De Les Illes Balears Composición que contiene ácido fítico, magnesio y polifenoles para el tratamiento o la prevención de la litiasis renal
US20170128469A1 (en) * 2014-06-25 2017-05-11 Universitat De Les Illes Balears Composition containing phytic acid, magnesium and polyphenols for the treatment or prevention of renal lithiasis
US11213535B2 (en) 2014-06-25 2022-01-04 Universitat De Les Illes Balears Composition containing phytic acid, magnesium and polyphenols for the treatment or prevention of renal lithiasis

Also Published As

Publication number Publication date
ES2058025B1 (es) 1995-10-01

Similar Documents

Publication Publication Date Title
CA2100212A1 (en) Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
CA2265766A1 (en) Rapidly disintegrating pellets
CA2148907A1 (en) Treatment of inflammatory bowel disease with ifn-gamma inhibitors
IL102571A0 (en) Pharmaceutical composition for the treatment of heart failure containing an inhibitor of neutral endopeptidase
ZA943744B (en) Therapeutic substituted guanidines
BG103793A (en) COMBINED THERAPY USING BENZOTHIAPINS INHIBITING THE ILEAL BILE ACID TRANSPORT AND HMG Co-A REDUCTASE INHIBITORS
DE69726577D1 (en) Kristallin form i von clarithromycin
UA41879C2 (uk) Засіб для лікування мотонейронових захворювань
AU3153097A (en) Pharmaceutical for treatment of neurological and neuropsychiatric disorders
HUP9803018A3 (en) Use of cyclooxygenase-2 inhibitors for producing pharmaceutical compositions suitable for the treatment and prevention of tumors, tumor-veloted disorders and cachexia
TW225534B (es)
TW268937B (es)
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
MY124648A (en) Inhibitor of factor xa alone or in combination with an anti-platelet aggregation agent, for combating arterial thrombosis.
IL110943A (en) Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
EP0460062A4 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
IL126683A0 (en) Pharmaceutical composition and method for the treatment of severe blood loss and for the inhibition or treatment of hemorrhagic shock
ITRM920222A0 (it) Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
IL88207A0 (en) Imidazole compounds and pharmaceutical compositions for the treatment of osteoporosis
AU1998588A (en) Method and therapeutic compositions for the prevention of fibrin deposition or adhesions
CA2055948A1 (en) Use of a combination of angiotensin-converting enzyme inhibitor and calcium antagonist for the treatment of proteinuria
ES2058025A1 (es) Aplicacion del acido fitico y/o sus fitatos en los estados patologicos y prepatologicos derivados de la litiasis renal oxalocalcica idiopatica.
MX9705916A (es) Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc.

Legal Events

Date Code Title Description
GC2A Exploitation certificate registered application with search report

Effective date: 19970423

FD2A Announcement of lapse in spain

Effective date: 20141120